GMP REGULATIONS

Effwa Infra and Research IPO is now open for subscription, aiming to raise Rs 51.27 crore. The company offers engineering and project management services in water pollution control. Investors can bid for shares at Rs 78-82 apiece.

Allied Blenders, post IPO debut, saw a 14% premium. The company holds 8% IMFL market share in India. Revenue grew by 9% and profit after tax by 50%. Facing financial volatility, it expanded the product portfolio with a strong brand presence.

The IPO, comprising a fresh issue of ₹1,000 crore and an offer for sale (OFS) of 1.77 crore existing shares, received overwhelming demand, with over 20 times subscription at its close. The company plans to utilize the funds from the fresh issue prim...

The IPO of Allied Blenders and Distillers was subscribed 23.49 times on its third and final day. NIIs show strong interest with 32 times subscription, followed by retail investors at 4.42 times. The QIB portion of the issue was booked 50 times. The ...

ABDL's IPO involves a fresh equity sale of Rs 1,000 crore and an offer for sale (OFS) of 1.77 crore shares by promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra. Funds raised will repay borrowings and fund corporate needs. The company's s...

Allied Blenders & Distillers IPO saw 51% subscription with promoters planning stake sale. Revenue grew 9% year-on-year to Rs 5,915 crore. ICICI Securities, Nuvama Wealth Management, and ITI Capital are the book running lead managers for the IPO.

With a strong financial performance and growth trajectory, our upcoming listing is poised for success. The oversubscribed IPO reflects investor confidence in our business model and potential for further expansion. Partnering with industry experts li...

Biocon received four observations from the US health regulator after a GMP inspection at its API facility in Andhra Pradesh.

Torrent Pharmaceuticals announced that the US Food and Drug Administration (USFDA) issued a Form 483 with five observations after inspecting its manufacturing plant in Indrad, Gujarat, from June 3 to June 12. The inspection included a pre-approval i...

In FY23, 30 companies undertook voluntary product recalls, while 16 were forced to recall their products, shows data sourced from Prime Database. Product recall information forms part of the business responsibility and sustainability reporting (BRSR...

Bharat Highways Invit IPO Allotment Status: Bharat Highways Invit IPO received strong institutional investor subscription. Share allotment to be finalized. Refunds on March 5, listing on March 6. Proceeds for debt repayment and corporate purposes. R...

Bharat Highways Invit IPO: Bharat Highways Invit is an infrastructure investment trust established to acquire, manage and invest in a portfolio of infrastructure assets in India and to carry on the activities of an infrastructure investment trust, a...

The issue comprises a fresh equity sale worth Rs 120 crore and an offer for sale (OFS) of 6.66 crore shares. Under the OFS, SAIF Partners, Peak XV Partners, Aloke Bajpai, Rajnish Kumar among others will offload shares.

Implementing the new GMP standard by 36 drug controllers in states and UTs is crucial, along with ensuring transparency and regulator accountability. India's trading partners, such as Gambia and Nigeria, have heightened scrutiny of Indian drug impor...

Maxposure IPO Allotment: The SME IPO Maxposure received the highest subscription so far in 2024 at nearly 905 times at close. Investors are eagerly awaiting the IPO allotment process for Maxposure. The IPO is a fresh equity issue of 61.4 lakh shares...

Maxposure IPO is completely a fresh equity issue of 61.4 lakh shares and through the issue, the company plans to raise Rs 20.26 crore. The net proceeds will be used for funding expenses incurred towards various certifications from various regulators...

The IPO of Maxposure, a new-age media and entertainment company, is generating strong investor interest. The issue has been oversubscribed by over 100 times on the second day of bidding, with the overall subscription at 106 times. Retail investors h...

Maxposure IPO opened for subscription and is garnering a bumper response from investors. The issue, which closes on January 17, was booked 24 times on the first day of bidding. The IPO is a fresh equity issue of up to 61.4 lakh shares, priced at Rs ...

More than 65% of MSME firms have been found to be manufacturing drugs that are not of standard quality (NSQ), during risk-based inspections of pharma companies conducted since December last year, said a person with knowledge of the matter.